Healthcare -
Drug Manufacturers - General - NYSE - US
$ 25.56
-0.583 %
$ 145 B
Market Cap
18.13
P/E
PFE - COST OF REVENUE
Cost of Revenue PFE - Pfizer Inc.
17.9 B
LAST VALUE
-27.90%
2 YEAR CAGR
11.80%
5 YEAR CAGR
6.42%
10 YEAR CAGR